Rituximab or a second anti-TNF therapy for rheumatoid arthritis patients who have failed their first anti-TNF? Comparative analysis from the British Society for Rheumatology Biologics Register
Arthritis Care & Research ,

Soliman MM et al. – The results suggest that switching to rituximab (RTX) may be of more benefit to switching to an alternative anti–tumour necrosis factor (anti–TNF) therapy after failing the first anti–TNF in Rheumatoid arthritis (RA) patients.

  • RA patients were registered with the British Society for Rheumatology Biologics Register.
  • Response to treatment six months after switching was assessed using:
    • (1) European League Against Rheumatism (EULAR) criteria
    • (2) improvements in Health Assessment Questionnaire (HAQ) score (0.22 units or more).
  • Regressionanalysis was used to compare EULAR response and improvement in HAQ between the two groups, adjusting for propensity scores.

  • In total, 1328 patients were included in the analysis of EULAR response and 937 patients were included inthe analysis of HAQ score.
  • Six months after switching, 54.8% of patients who switched to RTX were EULAR responders compared to 47.3% of those who switched to a second anti–TNF.
  • 38.4% of RTX patients achieved a clinically important improvement in HAQ compared to 29.6% in anti–TNF patients.
  • After adjustment using propensity scores, patients who switched to RTX were significantly more likely to achieve EULAR response; OR (95% CI) 1.31 (1.02, 1.69) compared to those who switched to an alternative anti–TNF.
  • RTX patients were also significantly more likely to achieve improvements in HAQ; (OR (95% CI) 1.49 (1.07, 2.08).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx


Most Popular Medical Student Articles

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List